Cited by 257Chronic Kidney Disease and DiabetesNutritional Studies and DietDialysis and Renal Disease Management

Soy Protein Intake, Cardiorenal Indices, and C-Reactive Protein in Type 2 Diabetes With Nephropathy

Open access
Azadbakht, Leila, Atabak, Shahnaz, Esmaillzadeh, Ahmad·2008·Diabetes Care

Abstract

OBJECTIVE—Several short-term trials on the effect of soy consumption on cardiovascular risks are available, but little evidence exists regarding the impact of long-term soy protein consumption among type 2 diabetic patients with nephropathy. To determine the effects of long-term soy consumption on cardiovascular risks, we measured C-reactive protein (CRP) and kidney function indexes among type 2 diabetic patients with nephropathy. RESEARCH DESIGN AND METHODS—This longitudinal randomized clinical trial was conducted among 41 type 2 diabetic patients with nephropathy (18 men and 23 women). Twenty patients in the soy protein group consumed a diet containing 0.8 g protein/kg body weight (35% animal proteins, 35% textured soy protein, and 30% vegetable proteins) and 21 patients in the control group consumed a similar diet containing 70% animal proteins and 30% vegetable proteins for 4 years. RESULTS—Soy protein consumption significantly affected cardiovascular risks such as fasting plasma glucose (mean change in the soy protein versus control groups: −18 ± 3 vs. 11 ± 2 mg/dl; P = 0.03), total cholesterol (−23 ± 5 vs. 10 ± 3 mg/dl; P = 0.01), LDL cholesterol (−20 ± 5 vs. 6 ± 2 mg/dl; P = 0.01), and serum triglyceride (−24 ± 6 vs. −5 ± 2 mg/dl; P = 0.01) concentrations. Serum CRP levels were significantly decreased by soy protein intake compared with those in the control group (1.31 ± 0.6 vs. 0.33 ± 0.1 mg/l; P = 0.02). Significant improvements were also seen in proteinuria (−0.15 ± 0.03 vs. 0.02 ± 0.01 g/day; P = 0.001) and urinary creatinine (−1.5 ± 0.9 vs. 0.6 ± 0.3 mg/dl, P = 0.01) by consumption of soy protein. CONCLUSIONS—Longitudinal soy protein consumption significantly affected cardiovascular risk factors and kidney-related biomarkers among type 2 diabetic patients with nephropathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc07-2065

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For people with DKD and macroalbuminuria, changing to a more soy-based source of protein may improve CVD risk factors but does not appear to alter proteinuria.

    “For people with DKD and macroalbuminuria, changing to a more soy-based source of protein may improve CVD risk factors but does not appear to alter proteinuria (322,323).”

    From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [323]

    The Results (p. 1) support improvement in cardiovascular risk factors but report a significant reduction in proteinuria with soy protein, contrary to the claim that it does not appear to alter proteinuria. The Results (p. 3) also note that the proteinuria finding lost significance after adjustment for changes in blood lipids; that qualification does not erase the reported unadjusted improvement. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • For people with DKD and macroalbuminuria, changing to a more soy-based source of protein may improve CVD risk factors but does not appear to alter proteinuria.

    “For people with DKD and macroalbuminuria, changing to a more soy-based source of protein may improve CVD risk factors but does not appear to alter proteinuria (322,323).”

    From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [322]

    The Methods (p. 1) describe patients with type 2 diabetic nephropathy and urinary protein excretion of 300–1,000 mg/day, but do not establish albumin-specific macroalbuminuria. The Results (p. 3) support improved cardiovascular risk factors, but report a significant reduction in proteinuria with soy; that finding lost significance only after adjustment for changes in blood lipids. Thus the claim that soy does not appear to alter proteinuria does not reflect the paper's overall finding. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Statins and angiotensin II receptor antagonists ameliorate the postprandial inflammatory response in obese patients.

    “Certain medications including statins and angiotensin II receptor antagonists ameliorate the postprandial inflammatory response in obese patients (167) .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Azadbakht, L., Atabak, S., & Esmaillzadeh, A.
Affiliations
  • Isfahan University of Medical Sciences (IR)
  • Shahid Beheshti University (IR)
Venue
Diabetes Care
Published
2008-04-01
Volume
31
Issue
4
Pages
648-654
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2118088187
Cited by
257
References
35
Citations by year
2026: 4 · 2025: 7 · 2024: 16 · 2023: 13 · 2022: 16 · 2021: 15 · 2020: 25 · 2019: 10 · 2018: 11 · 2017: 24 · 2016: 12 · 2015: 11 · 2014: 11 · 2013: 18 · 2012: 11
FWCI
14.21
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords
soy protein, type 2 diabetes, diabetic nephropathy, C-reactive protein, cardiovascular risk factors, renal function, proteinuria, LDL cholesterol, triglycerides, protein intake, textured soy protein, long-term dietary intervention
MeSH terms
Aged, C-Reactive Protein, Energy Intake, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Dietary Proteins, Female, Humans, Cholesterol, LDL, Longitudinal Studies, Male, Middle Aged, Triglycerides, Vegetables, Soybean Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review